Kintara Therapeutics

-$0.07 (-5.26%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KTRA and other stocks, options, and ETFs commission-free!

About KTRA

Kintara Therapeutics, Inc. Common Stock, also called Kintara Therapeutics, is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies.

CEO
Saiid Zarrabian
Employees
19
Headquarters
San Diego, California
Founded
2009

KTRA Key Statistics

Market Cap
41.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
303.33K
High Today
$1.33
Low Today
$1.25
Open Price
$1.30
Volume
292.09K
52 Week High
$3.35
52 Week Low
$0.5701

KTRA Earnings

-$0.36
-$0.12
$0.11
$0.35
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Aug 25, Pre-Market

You May Also Like

KINZ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure